These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6153169)

  • 1. Antigenic composition of a vaccine strain of Francisella tularensis.
    Holm SE; Tärnvik A; Sandström G
    Int Arch Allergy Appl Immunol; 1980; 61(2):136-44. PubMed ID: 6153169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antigenic structure of Francisella tularensis. II. Fractionation of the ether antigen on cellulose carriers and by gel filtration.
    Procházka O; Dubanská H
    Folia Microbiol (Praha); 1972; 17(4):300-7. PubMed ID: 4627016
    [No Abstract]   [Full Text] [Related]  

  • 3. The antigenic structure of Francisella tularensis. I. Isolation of the ether antigen and its fractionation.
    Procházka O; Dubanská H
    Folia Microbiol (Praha); 1972; 17(3):232-8. PubMed ID: 4624012
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein heterogeneity of Francisella tularensis: detection of proteins with antigenic determinants.
    Stulik J; Cerna J; Kovarová H; Macela A
    Folia Microbiol (Praha); 1989; 34(4):316-23. PubMed ID: 2481633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The C antigen of Francisella tularensis].
    Sukhar' VV; Uraleva VS
    Mikrobiol Zh (1978); 1992; 54(2):42-6. PubMed ID: 1374833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further Characterization of the Capsule-Like Complex (CLC) Produced by
    Champion AE; Bandara AB; Mohapatra N; Fulton KM; Twine SM; Inzana TJ
    Front Cell Infect Microbiol; 2018; 8():182. PubMed ID: 29963499
    [No Abstract]   [Full Text] [Related]  

  • 7. Live tularemia vaccine but not proteins purified from Francisella tularensis can confer protection against lethal Listeria infection in mice.
    Belyi YF; Petrosov VV; Tartakovskii IS; Suchkov YG
    APMIS; 1995 Feb; 103(2):107-12. PubMed ID: 7748535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Francisella tularensis vaccines.
    Griffin KF; Oyston PC; Titball RW
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tularemia vaccine strain is a potential vector].
    Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium.
    Cherwonogrodzky JW; Knodel MH; Spence MR
    Vaccine; 1994 Jul; 12(9):773-5. PubMed ID: 7975855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria].
    Aronova NV; Pavlovich NV
    Mol Gen Mikrobiol Virusol; 2001; (2):26-30. PubMed ID: 11449797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence.
    Fulop M; Manchee R; Titball R
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):245-7. PubMed ID: 8861037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.
    Robinson CM; Kobe BN; Schmitt DM; Phair B; Gilson T; Jung JY; Roberts L; Liao J; Camerlengo C; Chang B; Davis M; Figurski L; Sindeldecker D; Horzempa J
    Bioengineered; 2015; 6(2):82-8. PubMed ID: 25617059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components.
    Hambleton P; Evans CG; Hood AM; Strange RE
    Br J Exp Pathol; 1974 Aug; 55(4):363-73. PubMed ID: 4215444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new vaccine strains (or variants) of Francisella tularensis.
    Kormilitsyna MI; Meshcheryakova IS
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):215-9. PubMed ID: 8861032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
    Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
    PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro model system used to study adherence and invasion of Francisella tularensis live vaccine strain in nonphagocytic cells.
    Lindemann SR; McLendon MK; Apicella MA; Jones BD
    Infect Immun; 2007 Jun; 75(6):3178-82. PubMed ID: 17339345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.